Log in to save to my catalogue

Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population b...

Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population b...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6456811

Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study

About this item

Full title

Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study

Publisher

England: BMJ Publishing Group LTD

Journal title

BMJ (Online), 2019-04, Vol.365, p.l1204

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group LTD

More information

Scope and Contents

Contents

AbstractObjectiveTo investigate the incidence of new onset type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors (dutasteride or finasteride) for long term treatment of benign prostatic hyperplasia.DesignPopulation based cohort study.SettingUK Clinical Practice Research Datalink (CPRD; 2003-14) and Taiwanese National Health Insu...

Alternative Titles

Full title

Incidence of type 2 diabetes mellitus in men receiving steroid 5α-reductase inhibitors: population based cohort study

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6456811

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6456811

Other Identifiers

ISSN

0959-8138

E-ISSN

1756-1833

DOI

10.1136/bmj.l1204

How to access this item